A collection of blog posts connected to my teaching on biomedical sciences and biochemistry degrees. All views and opinions expressed are my own, and not connected to my past, present or future employers.
Over my career in bioscience, I’ve witnessed some incredible changes that have significantly changed how we do biomedical sciences and how cells work.
Recently, I was asked what I considered the most significant change in the biosciences I had seen. At first, I thought of the rise of omics technologies like genomics and proteomics, but after I thought about it some more, a few key innovations and changes in our thinking truly stood out.
In this blog post, I’ll tell you what I consider to be the major changes I have seen.
The PCR Revolution
When I first encountered PCR in the late 1980s, it seemed almost like a magic trick. The idea that you could heat a solution containing enzymes to 90°C and still get a reaction was mind-blowing. As a biochemist, the method seemed to go against what I had been taught on my degree - enzymes start to denature and stop working once you get above 40 ΒΊC.
Now, PCR is everywhere in the biosciences. It's used for research, criminal forensics, and disease diagnosis, and the ability to amplify DNA has changed the way we do science.
Another major technological leap I saw was the rise of easy-to-use mass spectrometers. Early in my career, mass spectrometry was a complex and inaccessible tool. However, the introduction of user-friendly mass spectrometers transformed lab work. Suddenly, we could easily measure the monoisotopic mass of peptides and carry out peptide mass fingerprinting to identify proteins with ease.
This shift was a game-changer for proteomics and molecular biology, enabling us to quickly identify proteins. The combination of advanced instruments and accessible databases allowed for faster, more detailed analyses that were once considered out of reach for most labs.
Bioinformatics
Bioinformatics has completely altered the way we approach science. Finding a scientific paper or sequence information in the past required extensive library work and manual searches. Now, with databases full of genetic sequences, protein structures, and published studies, the challenge has shifted from finding data to filtering and making sense of it.
When I started, labs had no computers at all. Now, every researcher has a personal computer linked to a global network of scientific knowledge and a vast array of powerful bioinformatic tools.
Adipocytes - the cells that changed
Beyond technological advances, our understanding of biology has also changed.
When I first started studying bioscience, adipocytes (fat cells) were considered passive storage units for energy. Today, they are recognised as dynamic endocrine organs that secrete a range of adipokines, influencing metabolism and overall health.
As we age, we tend to gain more fat cells, effectively adding to the number of these endocrine cells in our bodies. This shift in understanding has implications for obesity research, diabetes treatment, and metabolic health,
Mitochondria - not just a powerhouse
Our understanding of the mitochondrion—the "powerhouse" of the cell—has also changed.
Mitochondria were initially viewed as static structures within cells; however, we now know that mitochondria are dynamic organelles. They fuse, move, and interact with other cellular components, forming complex networks that help regulate cellular energy and even apoptosis (programmed cell death).
Like the mitochondria, our view of how the Golgi works has also changed. Previously, the Golgi was viewed as a series of membranes that looked like a stack of dinner plates, with the proteins being processed moving through the stack. Now, the machinery processing the proteins comes to the proteins, a radical change in our thinking.
My top picks
So, which do I view as the top change? Well, you will have to watch the video to find out!
The mitochondria, often called the "powerhouses" of the cell, provide the energy that keeps our bodies functioning. Interestingly, mitochondria carry their own DNA, separate from the DNA in the cell’s nucleus. This mitochondrial DNA (mtDNA) is passed down almost entirely from our mothers, and it plays a key role in producing proteins essential for the mitochondria's function.
However, mutations in mitochondrial DNA can lead to serious and sometimes life-threatening conditions, referred to as mitochondrial diseases. These diseases primarily affect high-energy tissues such as the brain, muscles, and heart, resulting in a range of debilitating symptoms.
What is Mitochondrial Replacement Therapy?
Mitochondrial replacement therapy (MRT) has been developed to combat these inherited mitochondrial conditions. This procedure aims to replace faulty mitochondria and prevent transmitting mitochondrial diseases from mother to child.
Here’s how it works:
An egg is taken from a healthy donor, and its nucleus is removed, leaving behind healthy mitochondria.
Then, the nucleus from the mother’s egg (who has mitochondrial disease) is transferred into the donor egg, essentially creating a new egg with the mother’s genetic material but the donor’s healthy mitochondria.
This egg is fertilised with the father’s sperm and implanted into the mother’s womb.
The result is a baby who inherits the vast majority of their DNA from their biological parents but receives mitochondria from a third-party donor. This process prevents the faulty mitochondria from being passed on, giving the baby a chance at a healthy life without mitochondrial disease.
Ethical Considerations of MRT
While mitochondrial replacement therapy has successfully prevented mitochondrial diseases, it comes with significant ethical considerations. Since mitochondria contain their own DNA, this procedure changes the genetic makeup of the individual born through MRT and their future offspring. This raises important questions about the long-term impact on the human gene pool and whether we should alter human genetics this way.
Despite these concerns, mitochondrial replacement therapy has already been performed in some countries, offering families the chance to have healthy children free from mitochondrial disease.
In this video - Understanding Mitochondrial DNA: Structure, Function, and Disease - I look at the mitochondria's circular DNA that contains 37 genes. I discuss how mitochondrial DNA (mtDNA) differs from nuclear DNA and can exhibit either homoplasmy or heteroplasmy. I then discuss how mitochondrial DNA is maternally inherited and not synchronised with cell division, leading to unique genetic traits and potential mitochondrial diseases that predominantly affect high-energy tissues. I wrap up by introducing the idea of how mitochondrial diseases can be treated using "three-parent babies" by replacing the nucleus of a donor egg with one from a mother with mitochondrial disease, effectively substituting the mutated mitochondria.
I finish up by highlighting that while the mitochondria can give the cell the energy it needs for life, they also play a role in cell death by releasing factors that trigger apoptosis.
In the video, I examine the history and functions of mitochondria. I start with Rudolf Albert von KΓΆlliker's initial description in 1852 and subsequent naming by Carl Benda in 1898. I explain how these organelles are more than just static power plants of the cell. I highlight the dynamic nature of mitochondria, their ability to form networks, and their crucial roles in energy production and cellular metabolism.
Proteins destined for the mitochondria begin their journey in the cell's cytosol, guided by a signal peptide that acts like a "postcode." This signal, located at the N-terminal of the precursor protein, directs the protein to the mitochondria.
The video looks at the role of the Translocase of the Outer Membrane (TOM) and the Translocase of the Inner Membrane (TIM), along with the OXA complex, during the import process and discusses how proteins are targeted to the outer and inner membranes, the intermembrane space and the matrix of the mitochondria.